ADVICENNE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.045 EUR | -0.73% |
|
+9.36% | -23.12% |
| 04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-25 | Advicenne: ODD designation in cystinuria | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 27.48M | - | |||||
| 89.69B | ||||||
| 41.34B | ||||||
| 33.72B | ||||||
| 26.11B | ||||||
| 14.63B |
- Stock Market
- Equities
- ALDVI Stock
- Charts Advicenne
- Sector Chart
